25 XP   0   0   10

Dawnrays Pharmaceutical Holdings Ltd
Buy, Hold or Sell?

Let's analyse Dawnrays together

PenkeI guess you are interested in Dawnrays Pharmaceutical Holdings Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dawnrays Pharmaceutical Holdings Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dawnrays Pharmaceutical Holdings Ltd

I send you an email if I find something interesting about Dawnrays Pharmaceutical Holdings Ltd.

Quick analysis of Dawnrays (30 sec.)










What can you expect buying and holding a share of Dawnrays? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.02
When do you have the money?
1 year
How often do you get paid?
96.6%

What is your share worth?

Current worth
HK$2.02
Expected worth in 1 year
HK$2.25
How sure are you?
96.6%

+ What do you gain per year?

Total Gains per Share
HK$0.37
Return On Investment
31.4%

For what price can you sell your share?

Current Price per Share
HK$1.17
Expected price per share
HK$1.15 - HK$1.35
How sure are you?
50%

1. Valuation of Dawnrays (5 min.)




Live pricePrice per Share (EOD)

HK$1.17

Intrinsic Value Per Share

HK$-0.70 - HK$-0.87

Total Value Per Share

HK$1.32 - HK$1.15

2. Growth of Dawnrays (5 min.)




Is Dawnrays growing?

Current yearPrevious yearGrowGrow %
How rich?$387.1m$327.2m$37.5m10.3%

How much money is Dawnrays making?

Current yearPrevious yearGrowGrow %
Making money$22.8m$18.7m$4m17.9%
Net Profit Margin17.0%15.5%--

How much money comes from the company's main activities?

3. Financial Health of Dawnrays (5 min.)




What can you expect buying and holding a share of Dawnrays? (5 min.)

Welcome investor! Dawnrays's management wants to use your money to grow the business. In return you get a share of Dawnrays.

What can you expect buying and holding a share of Dawnrays?

First you should know what it really means to hold a share of Dawnrays. And how you can make/lose money.

Speculation

The Price per Share of Dawnrays is HK$1.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dawnrays.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dawnrays, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$2.02. Based on the TTM, the Book Value Change Per Share is HK$0.06 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dawnrays.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.011.0%0.010.9%0.010.7%0.010.7%0.010.7%
Usd Book Value Change Per Share0.021.3%0.010.6%0.010.6%0.000.4%0.010.5%
Usd Dividend Per Share0.000.4%0.000.4%0.000.2%0.000.3%0.000.2%
Usd Total Gains Per Share0.021.7%0.011.0%0.010.7%0.010.7%0.010.7%
Usd Price Per Share0.15-0.16-0.19-0.17-0.35-
Price to Earnings Ratio3.26-3.91-5.65-5.79-13.24-
Price-to-Total Gains Ratio7.79-21.18-80.37-46.29-56.83-
Price to Book Ratio0.59-0.64-0.87-0.87-2.47-
Price-to-Total Gains Ratio7.79-21.18-80.37-46.29-56.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.149409
Number of shares6693
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.01
Gains per Quarter (6693 shares)78.4454.36
Gains per Year (6693 shares)313.77217.45
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111819630486131207
2236391618173262424
3355587932259393641
44737821246345525858
559197815604326561075
6709117318745187871292
7827136921886049181509
89461565250269110491726
910641760281677711801943
1011821956313086313112160

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%29.00.00.0100.0%48.00.00.0100.0%
Book Value Change Per Share2.00.02.050.0%6.00.06.050.0%10.00.09.052.6%20.00.09.069.0%39.00.09.081.3%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%18.00.01.094.7%28.00.01.096.6%47.00.01.097.9%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%18.00.01.094.7%28.00.01.096.6%47.00.01.097.9%

Fundamentals of Dawnrays

About Dawnrays Pharmaceutical Holdings Ltd

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong.

Fundamental data was last updated by Penke on 2024-04-16 06:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Dawnrays Pharmaceutical Holdings Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dawnrays earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 39.4% means that $0.39 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 39.4%. The company is making a huge profit. +2
  • The TTM is 17.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ39.4%TTM17.0%+22.4%
TTM17.0%YOY15.5%+1.5%
TTM17.0%5Y16.5%+0.5%
5Y16.5%10Y21.4%-5.0%
1.1.2. Return on Assets

Shows how efficient Dawnrays is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.2% Return on Assets means that Dawnrays generated $0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 7.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 4.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.2%TTM4.6%+2.5%
TTM4.6%YOY4.2%+0.4%
TTM4.6%5Y3.7%+1.0%
5Y3.7%10Y3.7%+0.0%
1.1.3. Return on Equity

Shows how efficient Dawnrays is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • 9.1% Return on Equity means Dawnrays generated $0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 9.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ9.1%TTM6.2%+2.9%
TTM6.2%YOY5.7%+0.5%
TTM6.2%5Y4.9%+1.3%
5Y4.9%10Y4.8%+0.1%

1.2. Operating Efficiency of Dawnrays Pharmaceutical Holdings Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dawnrays is operating .

  • Measures how much profit Dawnrays makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 14.7% means the company generated $0.15  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 14.7%. The company is operating less efficient.
  • The TTM is 7.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ14.7%TTM7.2%+7.5%
TTM7.2%YOY8.3%-1.1%
TTM7.2%5Y12.6%-5.3%
5Y12.6%10Y22.7%-10.2%
1.2.2. Operating Ratio

Measures how efficient Dawnrays is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.45 means that the operating costs are $0.45 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 0.452. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.218. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.452TTM0.218+0.234
TTM0.218YOY0.206+0.013
TTM0.2185Y0.340-0.121
5Y0.34010Y0.445-0.105

1.3. Liquidity of Dawnrays Pharmaceutical Holdings Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dawnrays is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.59 means the company has $2.59 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 2.587. The company is able to pay all its short-term debts. +1
  • The TTM is 2.229. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.587TTM2.229+0.358
TTM2.229YOY2.415-0.186
TTM2.2295Y2.807-0.578
5Y2.80710Y3.144-0.337
1.3.2. Quick Ratio

Measures if Dawnrays is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.01 means the company can pay off $3.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 3.010. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.546. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.010TTM1.546+1.464
TTM1.546YOY1.414+0.132
TTM1.5465Y1.707-0.161
5Y1.70710Y1.557+0.150

1.4. Solvency of Dawnrays Pharmaceutical Holdings Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dawnrays assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dawnrays to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.21 means that Dawnrays assets are financed with 21.1% credit (debt) and the remaining percentage (100% - 21.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 0.211. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.253. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.211TTM0.253-0.043
TTM0.253YOY0.259-0.005
TTM0.2535Y0.248+0.006
5Y0.24810Y0.240+0.008
1.4.2. Debt to Equity Ratio

Measures if Dawnrays is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 26.7% means that company has $0.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The MRQ is 0.267. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.342. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.267TTM0.342-0.075
TTM0.342YOY0.352-0.010
TTM0.3425Y0.332+0.010
5Y0.33210Y0.321+0.011

2. Market Valuation of Dawnrays Pharmaceutical Holdings Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Dawnrays generates.

  • Above 15 is considered overpriced but always compare Dawnrays to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 3.26 means the investor is paying $3.26 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The EOD is 3.175. Based on the earnings, the company is cheap. +2
  • The MRQ is 3.256. Based on the earnings, the company is cheap. +2
  • The TTM is 3.906. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.175MRQ3.256-0.081
MRQ3.256TTM3.906-0.650
TTM3.906YOY5.646-1.740
TTM3.9065Y5.790-1.884
5Y5.79010Y13.239-7.450
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The EOD is 33.066. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 33.914. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 34.409. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD33.066MRQ33.914-0.848
MRQ33.914TTM34.409-0.495
TTM34.409YOY14.567+19.842
TTM34.4095Y21.328+13.080
5Y21.32810Y23.619-2.291
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dawnrays is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Dawnrays Pharmaceutical Holdings Ltd:

  • The EOD is 0.579. Based on the equity, the company is cheap. +2
  • The MRQ is 0.594. Based on the equity, the company is cheap. +2
  • The TTM is 0.639. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.579MRQ0.594-0.015
MRQ0.594TTM0.639-0.046
TTM0.639YOY0.873-0.234
TTM0.6395Y0.870-0.231
5Y0.87010Y2.472-1.602
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dawnrays Pharmaceutical Holdings Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1190.057+109%0.051+134%0.038+211%0.046+160%
Book Value Per Share--2.0221.905+6%1.709+18%1.591+27%1.389+46%
Current Ratio--2.5872.229+16%2.415+7%2.807-8%3.144-18%
Debt To Asset Ratio--0.2110.253-17%0.259-19%0.248-15%0.240-12%
Debt To Equity Ratio--0.2670.342-22%0.352-24%0.332-20%0.321-17%
Dividend Per Share--0.0350.0350%0.018+96%0.025+37%0.023+52%
Eps--0.0920.080+16%0.065+41%0.064+45%0.061+51%
Free Cash Flow Per Share--0.0090.0090%0.028-69%0.022-60%0.031-72%
Free Cash Flow To Equity Per Share---0.017-0.017+0%0.013-228%-0.004-76%0.009-285%
Gross Profit Margin--1.0001.0000%1.0000%0.895+12%0.806+24%
Intrinsic Value_10Y_max---0.871--------
Intrinsic Value_10Y_min---0.698--------
Intrinsic Value_1Y_max--0.047--------
Intrinsic Value_1Y_min--0.046--------
Intrinsic Value_3Y_max--0.039--------
Intrinsic Value_3Y_min--0.039--------
Intrinsic Value_5Y_max---0.093--------
Intrinsic Value_5Y_min---0.077--------
Market Cap1754754243.840-3%1799751600.0001825995180.960-1%2223438603.840-19%2073364519.621-13%4292096528.028-58%
Net Profit Margin--0.3940.170+132%0.155+154%0.165+139%0.214+84%
Operating Margin--0.1470.072+103%0.083+76%0.126+17%0.227-35%
Operating Ratio--0.4520.218+107%0.206+120%0.340+33%0.445+2%
Pb Ratio0.579-3%0.5940.639-7%0.873-32%0.870-32%2.472-76%
Pe Ratio3.175-3%3.2563.906-17%5.646-42%5.790-44%13.239-75%
Price Per Share1.170-3%1.2001.218-1%1.483-19%1.357-12%2.718-56%
Price To Free Cash Flow Ratio33.066-3%33.91434.409-1%14.567+133%21.328+59%23.619+44%
Price To Total Gains Ratio7.597-3%7.79121.179-63%80.373-90%46.285-83%56.832-86%
Quick Ratio--3.0101.546+95%1.414+113%1.707+76%1.557+93%
Return On Assets--0.0720.046+55%0.042+71%0.037+96%0.037+97%
Return On Equity--0.0910.062+47%0.057+59%0.049+86%0.048+89%
Total Gains Per Share--0.1540.092+68%0.069+125%0.064+142%0.069+125%
Usd Book Value--387177796.468364782731.078+6%327239847.096+18%309898829.935+25%273783410.267+41%
Usd Book Value Change Per Share--0.0150.007+109%0.007+134%0.005+211%0.006+160%
Usd Book Value Per Share--0.2580.243+6%0.218+18%0.203+27%0.177+46%
Usd Dividend Per Share--0.0040.0040%0.002+96%0.003+37%0.003+52%
Usd Eps--0.0120.010+16%0.008+41%0.008+45%0.008+51%
Usd Free Cash Flow--1694191.1371694191.1370%5425369.094-69%4389780.895-61%6314069.542-73%
Usd Free Cash Flow Per Share--0.0010.0010%0.004-69%0.003-60%0.004-72%
Usd Free Cash Flow To Equity Per Share---0.002-0.002+0%0.002-228%-0.001-76%0.001-285%
Usd Market Cap224082116.938-3%229828279.320233179584.609-1%283933109.710-19%264768649.156-13%548100726.629-58%
Usd Price Per Share0.149-3%0.1530.155-1%0.189-19%0.173-12%0.347-56%
Usd Profit--35291822.22322872769.652+54%18780163.563+88%15654493.459+125%13513930.758+161%
Usd Revenue--89617767.76344956564.564+99%40679202.495+120%38382820.133+133%35666445.640+151%
Usd Total Gains Per Share--0.0200.012+68%0.009+125%0.008+142%0.009+125%
 EOD+4 -4MRQTTM+25 -9YOY+24 -115Y+24 -1210Y+23 -13

3.2. Fundamental Score

Let's check the fundamental score of Dawnrays Pharmaceutical Holdings Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-153.175
Price to Book Ratio (EOD)Between0-10.579
Net Profit Margin (MRQ)Greater than00.394
Operating Margin (MRQ)Greater than00.147
Quick Ratio (MRQ)Greater than13.010
Current Ratio (MRQ)Greater than12.587
Debt to Asset Ratio (MRQ)Less than10.211
Debt to Equity Ratio (MRQ)Less than10.267
Return on Equity (MRQ)Greater than0.150.091
Return on Assets (MRQ)Greater than0.050.072
Total9/10 (90.0%)

3.3. Technical Score

Let's check the technical score of Dawnrays Pharmaceutical Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.900
Ma 20Greater thanMa 501.185
Ma 50Greater thanMa 1001.215
Ma 100Greater thanMa 2001.141
OpenGreater thanClose1.170
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,557,356
Total Liabilities749,491
Total Stockholder Equity2,807,865
 As reported
Total Liabilities 749,491
Total Stockholder Equity+ 2,807,865
Total Assets = 3,557,356

Assets

Total Assets3,557,356
Total Current Assets1,660,665
Long-term Assets1,896,691
Total Current Assets
Cash And Cash Equivalents 66,615
Short-term Investments 601,497
Net Receivables 397,755
Inventory 221,637
Other Current Assets 2,578
Total Current Assets  (as reported)1,660,665
Total Current Assets  (calculated)1,290,082
+/- 370,583
Long-term Assets
Property Plant Equipment 1,207,156
Goodwill 241,158
Intangible Assets 295,208
Other Assets 148,122
Long-term Assets  (as reported)1,896,691
Long-term Assets  (calculated)1,891,644
+/- 5,047

Liabilities & Shareholders' Equity

Total Current Liabilities641,906
Long-term Liabilities101,445
Total Stockholder Equity2,807,865
Total Current Liabilities
Short-term Debt 32,340
Short Long Term Debt 32,340
Accounts payable 164,207
Other Current Liabilities 444,359
Total Current Liabilities  (as reported)641,906
Total Current Liabilities  (calculated)673,246
+/- 31,340
Long-term Liabilities
Long term Debt Total 113
Other Liabilities 101,332
Long-term Liabilities  (as reported)101,445
Long-term Liabilities  (calculated)101,445
+/-0
Total Stockholder Equity
Common Stock80,433
Retained Earnings 2,595,870
Capital Surplus 3,807
Other Stockholders Equity 27,580
Total Stockholder Equity (as reported)2,807,865
Total Stockholder Equity (calculated)2,707,690
+/- 100,175
Other
Capital Stock80,433
Cash And Equivalents264,534
Cash and Short Term Investments 932,646
Common Stock Shares Outstanding 1,499,793
Liabilities and Stockholders Equity 3,557,356
Net Invested Capital 2,840,205
Net Tangible Assets 2,271,499
Net Working Capital 1,018,759
Property Plant and Equipment Gross 1,207,156



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-302017-12-312017-06-302016-12-312016-06-302015-12-312015-06-302014-12-312014-06-302013-12-312013-06-302012-12-312012-06-302011-12-312011-06-302010-12-312010-06-302009-12-312009-06-302008-12-312008-06-302007-12-312007-06-302006-12-312006-06-302005-12-312005-06-302004-12-312004-06-30
> Total Assets 
602,474
687,083
688,954
745,053
804,642
758,337
787,031
851,398
930,289
975,215
1,059,979
1,126,465
1,251,644
1,413,157
1,519,897
1,393,816
1,486,968
1,569,643
1,668,263
1,721,148
1,668,759
1,693,400
1,845,157
1,803,736
1,866,879
1,886,364
1,980,411
2,181,211
2,435,998
2,366,029
0
2,652,853
0
2,786,387
0
2,805,822
0
2,903,735
0
2,863,598
0
3,339,558
0
3,284,288
0
3,672,643
0
3,557,356
3,557,35603,672,64303,284,28803,339,55802,863,59802,903,73502,805,82202,786,38702,652,85302,366,0292,435,9982,181,2111,980,4111,886,3641,866,8791,803,7361,845,1571,693,4001,668,7591,721,1481,668,2631,569,6431,486,9681,393,8161,519,8971,413,1571,251,6441,126,4651,059,979975,215930,289851,398787,031758,337804,642745,053688,954687,083602,474
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
608,574
674,018
726,227
839,485
964,112
1,023,129
822,697
859,196
921,891
1,003,605
1,019,185
962,908
989,935
1,159,089
1,133,223
1,201,919
1,242,454
1,307,416
1,527,142
1,796,047
1,710,338
0
1,630,473
1,715,183
1,715,183
1,633,775
1,633,775
1,548,714
1,548,714
1,478,254
1,478,254
1,511,036
1,511,036
1,446,399
1,446,399
1,743,995
1,743,995
1,660,665
1,660,665
1,660,6651,660,6651,743,9951,743,9951,446,3991,446,3991,511,0361,511,0361,478,2541,478,2541,548,7141,548,7141,633,7751,633,7751,715,1831,715,1831,630,47301,710,3381,796,0471,527,1421,307,4161,242,4541,201,9191,133,2231,159,089989,935962,9081,019,1851,003,605921,891859,196822,6971,023,129964,112839,485726,227674,018608,574000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
38,936
57,639
86,450
158,091
210,975
112,316
97,805
154,549
315,914
194,384
462,892
349,413
679,047
588,645
685,790
765,840
663,296
534,453
611,077
675,126
645,363
0
444,543
0
471,461
0
536,614
0
730,986
0
50,943
0
577,744
0
601,576
0
246,387
0
66,615
66,6150246,3870601,5760577,744050,9430730,9860536,6140471,4610444,5430645,363675,126611,077534,453663,296765,840685,790588,645679,047349,413462,892194,384315,914154,54997,805112,316210,975158,09186,45057,63938,936000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
3,404
4,927
5,814
40,792
55,944
60,077
4,707
4,948
5,705
5,445
5,896
5,984
5,440
3,745
3,683
6,678
7,794
8,154
457,743
584,941
539,393
0
628,416
0
645,830
0
526,401
0
201,192
0
142,509
0
208,184
0
255,330
0
581,357
0
601,497
601,4970581,3570255,3300208,1840142,5090201,1920526,4010645,8300628,4160539,393584,941457,7438,1547,7946,6783,6833,7455,4405,9845,8965,4455,7054,9484,70760,07755,94440,7925,8144,9273,404000000000
       Net Receivables 
191,314
245,098
216,848
239,505
313,398
288,892
304,878
341,170
343,869
391,041
419,396
435,308
418,770
499,495
494,991
442,989
451,522
402,922
420,469
381,203
256,186
200,062
232,844
282,173
257,666
225,660
265,239
184,853
185,463
199,614
0
227,837
370,994
370,994
308,813
308,813
330,747
330,747
426,420
426,420
367,578
367,578
306,036
306,036
402,850
402,850
397,755
397,755
397,755397,755402,850402,850306,036306,036367,578367,578426,420426,420330,747330,747308,813308,813370,994370,994227,8370199,614185,463184,853265,239225,660257,666282,173232,844200,062256,186381,203420,469402,922451,522442,989494,991499,495418,770435,308419,396391,041343,869341,170304,878288,892313,398239,505216,848245,098191,314
       Other Current Assets 
1,117
7,654
25,324
15,775
22,615
9,662
26,176
5,752
20,668
9,140
16,034
9,235
19,869
11,051
27,514
10,016
18,137
8,973
18,860
7,033
13,195
11,258
15,684
7,052
10,773
7,760
2,884
11,970
591,510
605,632
0
368,304
0
396,331
0
440,671
71
71
68,394
68,394
94,263
94,263
37,856
37,856
2,578
2,578
2,578
2,578
2,5782,5782,5782,57837,85637,85694,26394,26368,39468,3947171440,6710396,3310368,3040605,632591,51011,9702,8847,76010,7737,05215,68411,25813,1957,03318,8608,97318,13710,01627,51411,05119,8699,23516,0349,14020,6685,75226,1769,66222,61515,77525,3247,6541,117
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,022,380
0
1,071,204
0
1,172,047
0
1,355,021
0
1,385,344
0
1,828,522
0
1,837,889
0
1,928,648
0
1,896,691
1,896,69101,928,64801,837,88901,828,52201,385,34401,355,02101,172,04701,071,20401,022,3800000000000000000000000000000000
       Property Plant Equipment 
145,301
183,016
229,941
243,488
243,705
241,610
233,252
233,513
241,740
301,968
322,707
335,885
347,081
386,446
434,322
506,397
559,762
580,889
596,554
639,064
637,264
639,271
622,290
601,537
594,557
572,097
552,845
530,851
513,945
496,841
565,777
565,777
596,300
596,300
621,775
621,775
781,949
781,949
795,505
795,505
1,142,886
1,142,886
1,187,817
1,187,817
1,300,869
1,300,869
1,207,156
1,207,156
1,207,1561,207,1561,300,8691,300,8691,187,8171,187,8171,142,8861,142,886795,505795,505781,949781,949621,775621,775596,300596,300565,777565,777496,841513,945530,851552,845572,097594,557601,537622,290639,271637,264639,064596,554580,889559,762506,397434,322386,446347,081335,885322,707301,968241,740233,513233,252241,610243,705243,488229,941183,016145,301
       Goodwill 
0
0
0
0
0
0
583
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
241,158
0
241,158
0
241,158
0
241,158
0
241,158
0
241,158
0
241,158
0
241,158
0
241,158
241,1580241,1580241,1580241,1580241,1580241,1580241,1580241,1580241,158000000000000000000000000583000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,670
43,648
40,181
29,599
0
83,756
0
77,440
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000077,440083,756029,59940,18143,64848,67000000000000000000000000000
       Intangible Assets 
0
13,817
13,664
28,549
29,231
13,204
29,949
37,857
37,831
37,709
62,541
63,147
62,546
61,335
61,223
62,984
66,939
66,160
67,241
60,056
64,773
58,071
57,220
59,845
58,982
65,084
64,855
74,882
80,344
101,799
0
124,385
0
149,663
0
196,161
0
206,716
0
260,366
0
287,013
0
284,935
0
295,027
0
295,208
295,2080295,0270284,9350287,0130260,3660206,7160196,1610149,6630124,3850101,79980,34474,88264,85565,08458,98259,84557,22058,07164,77360,05667,24166,16066,93962,98461,22361,33562,54663,14762,54137,70937,83137,85729,94913,20429,23128,54913,66413,8170
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,022,380
0
1,071,204
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,071,20401,022,3800000000000000000000000000000000
> Total Liabilities 
219,168
274,896
247,090
255,996
298,996
245,290
243,249
272,392
332,745
346,002
404,928
414,621
483,131
578,203
645,607
474,938
552,517
587,531
640,338
629,411
512,576
445,120
505,955
329,860
345,889
249,608
274,167
375,053
536,649
444,867
0
677,268
0
760,075
0
702,686
0
720,143
0
656,607
0
941,697
0
794,253
0
1,030,687
0
749,491
749,49101,030,6870794,2530941,6970656,6070720,1430702,6860760,0750677,2680444,867536,649375,053274,167249,608345,889329,860505,955445,120512,576629,411640,338587,531552,517474,938645,607578,203483,131414,621404,928346,002332,745272,392243,249245,290298,996255,996247,090274,896219,168
   > Total Current Liabilities 
219,168
274,896
247,087
255,996
298,996
245,290
243,249
272,392
332,745
346,002
404,928
403,981
470,338
564,526
631,742
457,206
531,079
562,887
610,099
596,351
479,208
406,635
461,822
284,425
299,921
200,656
224,256
320,049
408,016
320,134
0
538,533
619,322
619,322
463,089
463,089
479,908
479,908
403,026
403,026
697,104
697,104
543,317
543,317
932,057
932,057
641,906
641,906
641,906641,906932,057932,057543,317543,317697,104697,104403,026403,026479,908479,908463,089463,089619,322619,322538,5330320,134408,016320,049224,256200,656299,921284,425461,822406,635479,208596,351610,099562,887531,079457,206631,742564,526470,338403,981404,928346,002332,745272,392243,249245,290298,996255,996247,087274,896219,168
       Short-term Debt 
0
0
0
0
0
0
0
0
0
3,404
4,927
5,814
40,792
55,944
60,077
4,707
4,948
5,705
5,445
5,896
5,984
5,440
3,745
3,683
6,678
7,794
8,154
457,743
584,941
539,393
0
628,416
0
645,830
0
526,401
0
0
0
9,245
0
21,013
0
24,292
0
6,434
0
32,340
32,34006,434024,292021,01309,245000526,4010645,8300628,4160539,393584,941457,7438,1547,7946,6783,6833,7455,4405,9845,8965,4455,7054,9484,70760,07755,94440,7925,8144,9273,404000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,104
0
0
80,284
0
0
197,378
0
216,776
0
113,399
0
0
0
9,245
0
21,013
0
24,292
0
6,434
0
32,340
32,34006,434024,292021,01309,245000113,3990216,7760197,3780080,284009,1040000000000000000000000000
       Accounts payable 
189,893
234,277
221,424
204,260
216,501
201,242
221,700
247,407
310,342
281,428
337,684
350,455
394,446
427,044
422,530
269,212
268,756
285,319
313,389
245,139
146,421
107,385
183,044
143,128
120,469
87,938
93,227
143,404
153,391
130,417
0
142,314
156,764
156,764
153,088
153,088
157,613
157,613
108,561
108,561
143,212
143,212
108,740
108,740
224,073
224,073
164,207
164,207
164,207164,207224,073224,073108,740108,740143,212143,212108,561108,561157,613157,613153,088153,088156,764156,764142,3140130,417153,391143,40493,22787,938120,469143,128183,044107,385146,421245,139313,389285,319268,756269,212422,530427,044394,446350,455337,684281,428310,342247,407221,700201,242216,501204,260221,424234,277189,893
       Other Current Liabilities 
29,275
40,619
25,663
34,110
23,290
18,697
21,549
24,985
22,403
39,667
39,135
46,765
39,252
86,326
67,379
77,536
66,147
75,817
63,107
103,036
99,015
110,982
118,376
132,450
170,951
103,614
131,029
176,645
174,341
88,789
0
198,841
146,147
146,147
196,100
196,100
179,992
179,992
284,305
284,305
374,957
374,957
409,252
409,252
700,016
700,016
444,359
444,359
444,359444,359700,016700,016409,252409,252374,957374,957284,305284,305179,992179,992196,100196,100146,147146,147198,841088,789174,341176,645131,029103,614170,951132,450118,376110,98299,015103,03663,10775,81766,14777,53667,37986,32639,25246,76539,13539,66722,40324,98521,54918,69723,29034,11025,66340,61929,275
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
138,735
0
140,753
0
239,597
0
240,235
0
236,653
0
244,593
0
250,936
0
90,719
0
101,445
101,445090,7190250,9360244,5930236,6530240,2350239,5970140,7530138,7350000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,660
0
2,841
0
2,420
0
2,025
0
1,613
0
1,527
0
995
0
444
0
113
1130444099501,52701,61302,02502,42002,84102,6600000000000000000000000000000000
       Other Liabilities 
0
0
3
0
0
0
0
0
0
0
0
1,120
0
0
0
1,500
1,945
2,094
3,594
3,884
3,884
3,475
3,475
2,683
2,683
2,248
2,248
1,878
128,633
124,733
136,075
136,075
137,912
137,912
237,177
237,177
238,210
238,210
235,040
235,040
243,066
243,066
249,941
249,941
90,275
90,275
101,332
101,332
101,332101,33290,27590,275249,941249,941243,066243,066235,040235,040238,210238,210237,177237,177137,912137,912136,075136,075124,733128,6331,8782,2482,2482,6832,6833,4753,4753,8843,8843,5942,0941,9451,5000001,12000000000300
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,562
0
34,090
0
61,962
0
0
125,170
125,170
0
0
170,535
170,535
0
0
216,943
216,943
0
0
0
0
0
0
000000216,943216,94300170,535170,53500125,170125,1700061,962034,090024,5620000000000000000000000000
> Total Stockholder Equity
382,610
411,471
441,154
488,314
504,907
512,257
543,019
578,352
596,896
628,541
654,492
711,289
767,960
834,954
874,290
918,878
934,451
982,112
1,027,925
1,091,737
1,156,183
1,248,280
1,339,202
1,473,876
1,520,990
1,636,756
1,706,244
1,806,158
1,899,349
1,921,162
0
1,975,585
0
2,025,636
0
2,089,599
0
2,170,503
0
2,206,991
0
2,380,714
0
2,472,723
0
2,641,956
0
2,807,865
2,807,86502,641,95602,472,72302,380,71402,206,99102,170,50302,089,59902,025,63601,975,58501,921,1621,899,3491,806,1581,706,2441,636,7561,520,9901,473,8761,339,2021,248,2801,156,1831,091,7371,027,925982,112934,451918,878874,290834,954767,960711,289654,492628,541596,896578,352543,019512,257504,907488,314441,154411,471382,610
   Common Stock
84,880
84,880
84,880
84,880
84,791
84,791
85,298
84,241
84,308
82,964
83,336
83,649
84,251
84,578
84,682
84,707
84,814
84,838
84,973
84,973
85,274
85,348
85,163
85,206
85,004
84,952
84,776
84,197
84,197
84,197
84,197
84,197
82,867
82,867
82,605
82,605
81,072
81,072
80,313
80,313
80,370
80,370
80,382
80,382
80,389
80,389
80,433
80,433
80,43380,43380,38980,38980,38280,38280,37080,37080,31380,31381,07281,07282,60582,60582,86782,86784,19784,19784,19784,19784,19784,77684,95285,00485,20685,16385,34885,27484,97384,97384,83884,81484,70784,68284,57884,25183,64983,33682,96484,30884,24185,29884,79184,79184,88084,88084,88084,880
   Retained Earnings 
104,835
123,087
185,637
202,487
247,721
255,652
283,289
28,224
350,725
315,860
413,518
34,769
520,986
52,472
521,627
548,341
680,984
559,430
637,596
639,078
740,815
748,515
902,417
1,015,312
1,065,932
1,148,289
1,225,799
1,315,103
1,404,470
1,380,516
1,740,217
1,449,172
1,795,516
1,476,012
1,860,881
1,541,377
1,940,426
1,940,426
2,001,333
2,001,333
2,174,453
2,174,453
2,269,745
2,269,745
0
2,554,740
2,595,870
2,595,870
2,595,8702,595,8702,554,74002,269,7452,269,7452,174,4532,174,4532,001,3332,001,3331,940,4261,940,4261,541,3771,860,8811,476,0121,795,5161,449,1721,740,2171,380,5161,404,4701,315,1031,225,7991,148,2891,065,9321,015,312902,417748,515740,815639,078637,596559,430680,984548,341521,62752,472520,98634,769413,518315,860350,72528,224283,289255,652247,721202,487185,637123,087104,835
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,160
26,160
26,160
0
17,581
0
0
0
0
0
0
0
0
0
2,521
0
2,773
0
2,911
0
3,807
3,80702,91102,77302,52100000000017,581026,16026,16026,160000000000000000000000000000
   Treasury Stock0000000000-430000-1610-3100000-92-740000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,574
23,113
-10,840
-10,816
-2,067
33,725
-10,949
47,239
47,239
45,938
45,938
49,260
49,260
25,170
25,170
23,195
23,195
19,648
19,648
2,561,567
2,561,567
27,580
27,580
27,58027,5802,561,5672,561,56719,64819,64823,19523,19525,17025,17049,26049,26045,93845,93847,23947,239-10,94933,725-2,067-10,816-10,84023,11321,5740000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue1,277,682
Cost of Revenue-511,004
Gross Profit766,678766,678
 
Operating Income (+$)
Gross Profit766,678
Operating Expense-829,303
Operating Income500,684-62,625
 
Operating Expense (+$)
Research Development79,478
Selling General Administrative263,791
Selling And Marketing Expenses0
Operating Expense829,303343,269
 
Net Interest Income (+$)
Interest Income61,980
Interest Expense-22,519
Other Finance Cost-20,457
Net Interest Income19,004
 
Pretax Income (+$)
Operating Income500,684
Net Interest Income19,004
Other Non-Operating Income Expenses0
Income Before Tax (EBT)438,408500,684
EBIT - interestExpense = 387,510
440,614
380,576
Interest Expense22,519
Earnings Before Interest and Taxes (EBIT)410,029460,927
Earnings Before Interest and Taxes (EBITDA)505,189
 
After tax Income (+$)
Income Before Tax438,408
Tax Provision-82,557
Net Income From Continuing Ops355,851355,851
Net Income358,057
Net Income Applicable To Common Shares358,057
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses12,380
Total Other Income/Expenses Net0-19,004
 

Technical Analysis of Dawnrays
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dawnrays. The general trend of Dawnrays is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dawnrays's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dawnrays Pharmaceutical Holdings Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.24 < 1.35 < 1.35.

The bearish price targets are: 1.15 > 1.15 > 1.15.

Tweet this
Dawnrays Pharmaceutical Holdings Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dawnrays Pharmaceutical Holdings Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dawnrays Pharmaceutical Holdings Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dawnrays Pharmaceutical Holdings Ltd. The current macd is -0.01589308.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dawnrays price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Dawnrays. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Dawnrays price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Dawnrays Pharmaceutical Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) ChartDawnrays Pharmaceutical Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dawnrays Pharmaceutical Holdings Ltd. The current adx is 17.97.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Dawnrays shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Dawnrays Pharmaceutical Holdings Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dawnrays Pharmaceutical Holdings Ltd. The current sar is 1.23129222.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Dawnrays Pharmaceutical Holdings Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dawnrays Pharmaceutical Holdings Ltd. The current rsi is 43.90. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
Dawnrays Pharmaceutical Holdings Ltd Daily Relative Strength Index (RSI) ChartDawnrays Pharmaceutical Holdings Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dawnrays Pharmaceutical Holdings Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dawnrays price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Dawnrays Pharmaceutical Holdings Ltd Daily Stochastic Oscillator ChartDawnrays Pharmaceutical Holdings Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dawnrays Pharmaceutical Holdings Ltd. The current cci is -48.58299595.

Dawnrays Pharmaceutical Holdings Ltd Daily Commodity Channel Index (CCI) ChartDawnrays Pharmaceutical Holdings Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dawnrays Pharmaceutical Holdings Ltd. The current cmo is -14.11975162.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Dawnrays Pharmaceutical Holdings Ltd Daily Chande Momentum Oscillator (CMO) ChartDawnrays Pharmaceutical Holdings Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dawnrays Pharmaceutical Holdings Ltd. The current willr is -77.77777778.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Dawnrays is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Dawnrays Pharmaceutical Holdings Ltd Daily Williams %R ChartDawnrays Pharmaceutical Holdings Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dawnrays Pharmaceutical Holdings Ltd.

Dawnrays Pharmaceutical Holdings Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dawnrays Pharmaceutical Holdings Ltd. The current atr is 0.03289552.

Dawnrays Pharmaceutical Holdings Ltd Daily Average True Range (ATR) ChartDawnrays Pharmaceutical Holdings Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dawnrays Pharmaceutical Holdings Ltd. The current obv is -4,043,015.

Dawnrays Pharmaceutical Holdings Ltd Daily On-Balance Volume (OBV) ChartDawnrays Pharmaceutical Holdings Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dawnrays Pharmaceutical Holdings Ltd. The current mfi is 32.51.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Dawnrays Pharmaceutical Holdings Ltd Daily Money Flow Index (MFI) ChartDawnrays Pharmaceutical Holdings Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dawnrays Pharmaceutical Holdings Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Dawnrays Pharmaceutical Holdings Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dawnrays Pharmaceutical Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.900
Ma 20Greater thanMa 501.185
Ma 50Greater thanMa 1001.215
Ma 100Greater thanMa 2001.141
OpenGreater thanClose1.170
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dawnrays with someone you think should read this too:
  • Are you bullish or bearish on Dawnrays? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dawnrays? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dawnrays Pharmaceutical Holdings Ltd

I send you an email if I find something interesting about Dawnrays Pharmaceutical Holdings Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Dawnrays Pharmaceutical Holdings Ltd.

Receive notifications about Dawnrays Pharmaceutical Holdings Ltd in your mailbox!